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416 The Journal of Thoracic and CardioObjective: Early failure of the Fontan-type circulation is a potentially fatal compli-
cation. We review our experience with cardiac transplantation in children presenting
with end-stage heart failure in this scenario.
Methods: We performed a retrospective review. Between 1985 and 2003, 6 children
aged less than 16 years were referred for cardiac transplantation. The indication for
cardiac transplantation was end-stage cardiac failure early after the completion of
the Fontan-type operation.
Results: All 6 patients listed for transplantation underwent cardiac transplantation;
the median interval to transplantation from the operation was 36 days (range, 6-180
days). Four patients had undergone the Fontan procedure, and 2 had one-and-a-
half-ventricle repair. All 6 patients were ventilated and inotrope dependant, with
varying degrees of multiorgan dysfunction. One patient was bridged to transplan-
tation with extracorporeal membrane oxygenation. The median age at transplanta-
tion was 7.1 years (range, 3-12.5 years), and weight was 18.9 kg (range, 11-35 kg).
One patient died on the operating table (graft failure and hemorrhage). In 5 survivors
the median intensive care unit stay was 10 days (range, 8-61 days). On follow-up of
6 to 81 months, there have been no subsequent deaths, and the quality of life in
survivors is good.
Conclusion: Rescue cardiac transplantation in the setting of an early failure of the
Fontan-type circulation and end-stage cardiac failure is an effective treatment option
and can be performed with acceptable early mortality and encouraging short-term to
medium-term results.
Cardiac transplantation in infants and children has evolved consid-erably over the past 2 decades.1-5 Five-year survival is currentlyapproaching 90% in the cardiomyopathy group and 80% in thosewith congenital heart disease as a primary diagnosis.1,4,6In 1971, the Fontan procedure was initially conceived for apatient with tricuspid atresia.7 Since then, it has been established as
a definitive palliation for cardiac anomalies with a single functional ventricle or 2
ventricles with anatomy unsuitable for biventricular repair.8-10 Early failure of the
Fontan circulation within 30 days of an operation is a potentially fatal complica-
tion.11,12 The conventional approach in this situation is to take down the Fontan
vascular Surgery ● February 2005
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TXcirculation. This approach, however, is associated with very
high mortality and an uncertain long-term future.11,12 An
alternative strategy of cardiac transplantation as a life-sav-
ing and life-enhancing therapy seems attractive because it
provides normal cardiac anatomy and physiology. Cardiac
transplantation for late failure of the Fontan circulation has
been reported previously, with variable success.4,13-16 Indi-
TABLE 1. Patient characteristics
Patients Patient 1 Patient 2 Pa
Sex Male Male Male
Diagnosis Dextrocardia,
CAVSD, PS,
LV
hypoplasia
PA-IVS, RV
hypoplasia, RV
to coronary
fistula
RAI, CAV
bilatera
Previous
operations
Classical
RMBT
shunt
RMBT shunt, BDG
shunt; repair of
RPA
LMBT sh
BDG sh
Preoperative HD
(mm/Hg)
PAM 13 10 15
SVEDP (U/m2) 4 8 12
TPR 2.2 4.0 3.9
PAVR 1.4 1.9 2.6
Age at
operation (y)
12 4.3 7.3
Operation TCPC, lateral
tunnel
Extracardiac
Fontan, 18-mm
PTFE tube
Extracard
20-mm
Fenestration 4 mm No 5 mm
Mechanisms for
failure
SV
dysfunction,
common
AVVR,
atrial
tachycardia
LV dysfunction,
ventricular
tachycardia
SV dysfun
commo
Intervention Nil Fenestration,
cardiac ECMO
Nil
OP-TXP (d) 180 16 6
TXP W/L 21 14 3
CAVSD, Complete atrioventricular septal defect; PS, pulmonary stenosis; L
ventricle; RAI, right atrial isomerism; TGA, transposition of the great arterie
aorta; ASD, atrial septal defect; TVR, total vascular resistance; RMBT,
Blalock-Taussig; PAB, pulmonary artery band; HD, hemodynamics; PAM
pressure; TPR, total pulmonary resistance; PAVR, pulmonary arteriolar re
polytetrafluoroethylene (Gore-Tex; W. L. Gore & Associates, Inc, Flagstaff,
valve regurgitation; PR, pulmonary resistance; ECMO, extracorporeal me
waiting list.cations for transplantation in this group are protein-losing
The Journal of Thoracienteropathy, intractable atrial arrhythmia, and systemic ven-
tricular dysfunction. Early failure of the Fontan-type circu-
lation is a life-threatening complication, and the therapeutic
options are limited. To our knowledge, this is the first series
of rescue cardiac transplantation for early failure of the
Fontan-type circulation in children. Technical challenges in
peritransplant intensive care and cardiac transplantation sur-
3 Patient 4 Patient 5 Patient 6
Male Male Female
GA, PA,
s
TGA, VSD, PS, LV
hypoplasia
CAVSD, CoA, LV
hypoplasia
Severe
Epstein,
large ASD,
TVR
ilateral RMBT shunt, BDG
shunt
CoA repair-PAB,
BDG shunt
None
15 14 —
11 11 —
3.2 4.0 —
1.6 3.5 —
7.6 3.0 6.5
ontan,
tube
One-an-a-half
repair, IVC
Senning to LV,
LV to PA
conduit, VSD
closure
Extracardiac
Fontan, 18-mm
PTFE tube,
LPA plasty
One-and-a-
half repair,
tricuspid
valve
repair, BDG
shunt, ASD
closure
4 mm
,
VR
SV dysfunction,
systemic AVVR,
SVC syndrome
SV dysfunction,
left phrenic
Palsy
LV
dysfunction,
severe PR
RPA banding,
catheter
occlusion of
RPA band
Nil Nil
135 12 56
16 2 27
ventricle; PA, pulmonary atresia; IVS, intact ventricular septum; RV, right
C, superior vena cava; VSD, ventricular septal defect; CoA, coarctation of
modified Blalock-Taussig; BDG, bidirectional Glenn; LMBT, left modified
onary artery mean pressure; SVEDP, systemic ventricular end-diastolic
ce; SV, systemic ventricle; TCPC, total cavopulmonary connection; PTFE,
IVC, inferior vena cava; LPA, left pulmonary artery; AVVR, atrioventricular
ne oxygenation; RPA, right pulmonary artery; TXP, transplantation; W/L,tient
SD, T
l SVC
unt, b
unt
iac F
PTFE
ction
n AV
V, left
s; SV
right
, pulm
sistan
Ariz);
mbragery are discussed.
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TXPatients and Methods
Between 1985 and 2003, a total of 110 cardiac transplantations
were performed in 107 children less than 16 years of age. Six
patients described in this report were referred to our institution for
cardiac transplantation assessment after early failure of the Fontan-
type circulation.
Patient Characteristics
Table 1 summarizes the clinical and hemodynamic data on these
TABLE 2. Pretransplantation status
Patients Patient 1 Patient 2
Weight (kg) 35 17 21
Respiratory support Ventilation Ventilation Ve
Inotropes (g ·
kg1 · min1)
Dobutamine 10 10 —
Milrinone 0.75 0.7 0.5
Epinephrine — 0.1 0.1
Norepinephrine — 0.2 0.1
Dopamine — 4.0 —
Comorbidity
Pleural effusion —  
Ascites — — 
Renal
impairment
Ur: 14, Cr: 120 Ur: 22, Cr: 278 Ur
GFR (mL · min1
· 1.74 m2)
44 15 48
Liver impairment Bili: 89,
ALP: 124,
ALT: 167
— Bil
Coagulopathy — — —
Sepsis — — —
Other interventions Pleural
drainage,
cardiac
ECMO
Ple
Cardiac
catheterization
Fontan pathways No
obstruction
No
obstruction
No
Fenestration Patent Patent Pa
PAM (mm Hg) 14 21
SVEDP (mm Hg) 12 12
Echocardiography Poor SV
function,
severe
AVVR
Poor LV
function
Po
NO, Nitric oxide; Ur, serum urea level in millimoles per liter; Cr, serum cre
in micromoles per liter; ALP, serum alkaline phosphatase in units per liter
milligrams per liter; ECMO, extracorporeal membrane oxygenation; TPN, to
SVEDP, systemic ventricular end-diastolic pressure; SV, systemic ventriclpatients. Four patients had undergone a modified Fontan operation,
418 The Journal of Thoracic and Cardiovascular Surgery ● Febrand the remaining 2 patients had undergone a one-and-a-half-
ventricle repair operation. All 6 patients were separated from
cardiopulmonary bypass after completion of the operation. Four
patients (patients 2, 3, 5, and 6) were referred for cardiac trans-
plantation after failure in weaning off ventilatory and inotropic
support and progressive cardiac failure in the early postoperative
period. Patients 1 and 4 were noted to have severe systemic
ventricular dysfunction with significant systemic atrioventricular
valve regurgitation in the early postoperative period. Onset of
nt 3 Patient 4 Patient 5 Patient 6
20.8 11 15
ion  Ventilation 
NO
Ventilation 
NO
Ventilation
10 — 10
0.75 0.75 0.75
0.1 1.0 0.05
— — —
— — —
  
 — —
Cr: 99 Ur: 11.4, Cr: 59 Ur: 12, Cr: 75 Ur: 8, Cr: 81
80 49 50
61,
11
Bili: 16,
ALP: 98,
ALT: 72
Bili: 47,
ALP: 43,
ALT: 83
Bili: 174,
ALP: 104,
ALT: 42
—  
CRP: 212 — —
age,
neal
age,
Pleural
drainage,
peritoneal
drainage,
TPN
Pleural drainage,
peritoneal
dialysis,
cardiac,
pacing,
surface
cooling
Pleural
drainage
uction
No
obstruction
No
obstruction
No
obstruction
— Patent —
Rt: 20, Lt: 28 25 19
16 12 11
ion,
rate
Poor SV
function,
severe
AVVR
Poor SV
function,
moderate
AVVR
Poor LV
function,
severe
PR
e in millimoles per liter; GFR, glomerular filtration rate; Bili, serum bilirubin
, serum alanine transaminase in units per liter; CRP, C-reactive protein in
renteral nutrition; PAM, pulmonary artery mean pressure; Rt, right; Lt, left;
VR, atrioventricular valve; PR, pulmonary regurgitation.Patie
ntilat
NO
5
: 9.0,
i: 21,
ALP:
ALT:
ural
drain
perito
drain
TPN
obstr
tent
or SV
funct
mode
AVVR
atinin
; ALT
tal paintractable atrial arrhythmias in patient 1 and superior vena caval
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TXhypertension syndrome in patient 4 led to end-stage cardiac failure
and referral for cardiac transplantation. All 6 patients received a
cardiac transplant; the median interval from operation to transplan-
tation was 36 days (range, 6-180 days). There were no deaths
while waiting on the transplant list after early failure of the
Fontan-type circulation.
Pretransplantation Status
Table 2 summarizes the clinical condition of these patients before
cardiac transplantation and the details of multiorgan support. Car-
diac catheterization was performed in 5 patients and revealed
unobstructed cavopulmonary pathways and increased systemic
venous pressure. Fenestration was patent in the 3 patients and
introduced in the Fontan circulation after early Fontan failure in
patient 2. The mechanism for the early failure of the Fontan-type
circulation in this group of patients was multifactorial, predomi-
nantly being a combination of systemic ventricular dysfunction
(fractional shortening 10%) and significant systemic atrioven-
tricular valve regurgitation (grade III-IV). Intractable cardiac ar-
rhythmias were present in 2 patients. In addition, superior vena
caval hypertension syndrome in patient 4 and severe pulmonary
regurgitation in patient 6 were contributory factors for the failure
of one-and-a-half-ventricle repair.
Transplant Operation
The technique of the transplant operation in this scenario differs
from the usual technique in 2 respects: the pulmonary arteries
require reconstruction, and the systemic venous drainage might
TABLE 3. Donor and recipient sizes
Patients
Recipient Donor
Height
(cm)/weight (kg)
Height
(cm)/weight (kg)
1 156 35 160 76
2 102 17 154 47
3 119 21 157 55
4 118 20.8 160 65
5 92 11 137 26
6 102 15 125 25
TABLE 4. Posttransplantation complications
Patients Patient 1 Patient 2 Patient
Comorbidity Bilateral
empyema
RV failure,
bleeding
Bowel perforat
obstruction,
chylothorax,
Interventions Pleural
drainage
Nil Ileostomy, trac
pleural drain
ICU stay (d) 10 — 31
Outcome Survival Death Survival
Follow-up (mo) 81 — 15
Functional class
(NYHA)
Class I Class IRV, Right ventricle; URT, upper respiratory tract; ARF, acute renal failure; ICU,
The Journal of Thoracirequire redirection. The pulmonary artery reconstruction was un-
dertaken with bovine pericardium in 5 patients and with pulmo-
nary homograft in 1 patient. In patient 3 the left superior vena cava
was anastomosed to the right atrial appendage, with the right
superior vena cava (SVC) being anastomosed to the donor SVC.
We deliberately oversized the donor heart because of concerns
regarding increase in pulmonary vascular resistance (Table 3).
Postoperatively, all the patients were managed with the standard
pediatric protocol of immunosuppression. This included induction
therapy with equine antithymocyte globulin in 4 patients and
interleukin 2 antagonist in 2 patients. Maintenance immunosup-
pression was achieved with a combination of cyclosporine (INN:
ciclosporin), azathioprine, and steroids.
Results
Early Results
One patient died on the operating table as a result of graft
failure and hemorrhage. Posttransplantation morbidity (Ta-
ble 4) included gut dysfunction–bowel perforation requiring
surgical intervention and prolonged dependence on paren-
teral nutrition in patient 3, acute renal failure requiring
venovenous hemofiltration in patient 5, and prolonged ven-
tilatory dependence necessitating tracheostomy in patients 3
and 5. Cyclosporine toxicity causing seizures was seen in
patient 6. The intensive care unit stay ranged from 8 to 61
days (median, 10 days).
Late Results
On follow-up of 6 to 81 months, there have been no sub-
sequent deaths. Tracheostomy decannulation was accom-
plished in patients 3 and 5 before hospital discharge, and
patient 3 underwent reversal of the ileostomy 3 months after
transplantation. Quality of life in 5 survivors is good, with
normal heart function and no evidence of rejection on
endomyocardial biopsy.
Discussion
Early Fontan Failure
Failure of the Fontan circulation in the early postoperative
period is a potentially fatal complication. In a series of 702
Patient 4 Patient 5 Patient 6
RT
is
Nil ARF, URT
obstruction,
sepsis
Seizures,
hyperbilirubinemia
tomy, Nil Hemofiltration,
tracheostomy
Nil
8 61 8
Survival Survival Survival
9 8 6
Class I Class I Class I3
ion, U
seps
heos
ageintensive care unit; NYHA, New York Heart Association.
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TXconsecutive patients who underwent modified Fontan oper-
ations at the Mayo Clinic,11 early failure was seen in 104
(14.8%) patients. Successful takedown of the repair was
performed in 6 patients, and the remaining 98 patients died
in the early postoperative period. In a similar study of the
first 500 patients undergoing the modified Fontan operation
at the Children’s Hospital Boston,12 early failure was noted
in 84 (16.8%) patients. From this group, takedown of the
operation was successful in 10 patients: 20 patients died
with the takedown operation, and the remaining 54 patients
died with Fontan circulation.
In the current era, creation of smaller aortopulmonary
shunts, attention to systemic outflow tract obstruction and
atrioventricular valve regurgitation, staging of the Fontan
procedure, extracardiac Fontan modification, routine use of
fenestration, and modified ultrafiltration during cardiopul-
monary bypass are the strategies responsible for the signif-
icant decrease in the incidence of early Fontan failures,
despite a widening application of the Fontan procedure to
high-risk patients.11,12,17,18
Pre-Fontan Hemodynamic Assessment
Early failure of the Fontan-type operations, despite appar-
ently satisfactory preoperative assessment, highlights the
limitations of the techniques of hemodynamic and ventric-
ular function assessment in these patients. Current tech-
niques of hemodynamic assessment in this group of patients
are often limited by low pulmonary blood flow and do not
allow assessment of pulmonary vasculature under different
loading conditions. M-mode and cross-sectional echocardi-
ography are conventionally used to evaluate ventricular
volume and function, and their accuracy depends on the
ability to obtain a desired cross-sectional view and accurate
geometric volume assumption. They are of limited value in
TABLE 5. Algorithm for management of early Fontan failure
Early Fontan failure
2
Identify the mechanism for the failure (ECG/echocardiography/
cardiac catheter)
2
1. Arrhythmia: medications/ablation procedure
2. AVVR: valve repair/replacement
3. Systemic venous hypertension
A. Obstruction to Fontan pathways: relief of obstruction
stenting/surgery
B. Increased pulmonary vascular resistance: Fontan
fenestration/? pulmonary vasodilators/take down to AP shunt
4. Pump failure: Inotropes/mechanical support/cardiac
transplantation
5. 4  1/2/3: Inotropes/mechanical support/cardiac transplant
ECG, Electrocardiography; AVVR, atrioventricular valve regurgitation; AP,
aortopulmonary.the context of a functioning single ventricle because of
420 The Journal of Thoracic and Cardiovascular Surgery ● Febrcomplex structural geometry and numerous variations in the
ventricular morphology. Stumper and colleagues19 have
proposed a catheter technique to provide a 2-point hemo-
dynamic assessment of the pulmonary vasculature before
the Fontan operation. Ventricular time-volume curves ob-
tained by means of radionuclide angiography,20 magnetic
resonance imaging,21 or real-time 3-dimensional echocardi-
ography22 are likely to provide reliable quantitative data on
the global ventricular performance in the future.
Management of Early Fontan Failure
The pathophysiology of the early failure of the Fontan
circulation is characterized by a combination of increased
systemic venous pressure and a low cardiac output state.
This initiates a cascade of events that results in tissue
edema, hypoxia, and organ hypoperfusion, culminating in
multiorgan failure and death. Early cardiac catheterization
is mandatory to exclude fenestration occlusion, obstruction
to the cavopulmonary pathways, and assessment of
transpulmonary gradient.
Our ventilation strategy was aimed at maintenance of
functional residual capacity while minimizing mean airway
pressure to keep pulmonary vascular resistance at as low a
level as possible, thereby optimizing pulmonary blood flow
and ventricular preload. Three patients in this series also
received nitric oxide. Pleural and peritoneal effusions re-
duce chest compliance and were aggressively drained. We
preferred a combination of phosphodiesterase inhibitor
(milrinone) and a catecholamine (dobutamine or epineph-
rine) for inotropic support in these patients. Milrinone has
been shown to have beneficial effects after pediatric cardiac
surgery and has favorable effects on pulmonary vascular
resistance.23 Minimizing exogenous use of catecholamine
might have particular benefit for these patients in view of
the adverse effects of catecholamines on splanchnic blood
flow,24 as well as adrenoreceptor downregulation before
transplantation. Multiorgan dysfunction can manifest as re-
nal failure, gastrointestinal dysfunction, and hepatic dys-
function necessitating meticulous multidisciplinary inten-
sive care management. We recommend early use of
parenteral nutrition in combination with low-dose trophic
volumes of enteral feeding and selective decontamination of
the digestive tract to prevent gastrointestinal malfunction.
Tissue hypoxia, edema, and loss of proteinaceous exudates
render these patients susceptible to infection. A high degree
of suspicion for sepsis is therefore required coupled with
rigorous microbiologic surveillance.
Mechanical circulatory support for patients with failing
Fontan circulation has been described.25,26 A recent report
describes the use of extracorporeal membrane oxygenation
as an effective mechanical circulatory support for patients
with failing Fontan circulation.27 This approach can be used
as a short-term resuscitative measure as a bridge to recov-
uary 2005
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as a bridge to transplantation. Morbidity and mortality as-
sociated with mechanical support for the failing Fontan
circulation is still substantial,25-27 and the outcome is par-
ticularly unfavorable in patients with progressive multisys-
tem organ dysfunction. Patient 2 in our series was bridged
to transplantation with extracorporeal membrane oxygen-
ation. In addition, 2 other patient in our series were elec-
tively cooled to a core temperature of 34°C to 35°C to
reduce systemic oxygen consumption when their own oxy-
gen-delivery capability was severely compromised.
On the basis of the predominant mechanism for the
failure, we suggest an algorithm for the management of
early Fontan failure (Table 5). In our patients we decided to
go down the cardiac transplantation route because the mech-
anism for the failure of the Fontan-type circulation was
multifactorial, there were no other viable surgical options
available, and the patients were in end-stage cardiac failure
with progressive multisystem organ dysfunction.
Cardiac Transplantation for Early Fontan Failure
Heart transplantation in the setting of a failing Fontan
circulation is technically challenging.4,15,16 It requires re-
construction of pulmonary arteries, redirection of systemic
venous connections, and appropriate siting of what is fre-
quently an oversized heart. Use of oversized donor hearts
has been shown to be safe for pediatric cardiac transplan-
tation.28,29 We also used oversized donor hearts with a size
mismatch of up to 300% relative to the recipient, which
allowed us to use the available donors. The adverse conse-
quences of this approach are delayed sternal closure, per-
sistent left lower lobe collapse, and systemic hypertension.
In contrast to our own results, the mortality of heart trans-
plantation after Fontan failure has been reported by others to
be as high as 44% to 66%.14,15 Our experience shows that
rescue cardiac transplantation is a viable option in the
setting of early failure of the Fontan-type circulation, and
the short-term to medium-term results are encouraging. In
the future, primary cardiac transplantation might be the
preferred management option for a high-risk Fontan opera-
tion in childhood.
Conclusion
Cardiac transplantation, although technically challenging, is
an effective treatment option in the event of early failure of
the Fontan-type circulation in children. Early referral for
transplant assessment should be sought in the event of early
failure of the Fontan-type circulation to avoid multiorgan
dysfunction–related morbidity and mortality and to allow
for procurement of a suitable donor heart.
We thank Professor John Dark and Dr Kate Gould for their help
in preparation of this article.
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